A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis.S R Muthuramalingam, Trivadi S. Ganesan, Timothy Perren et al.|PubMed|2011Cited by 7
A randomised trial of carboplatin versus carboplatin and thalidomide in ovarian cancer, with evaluation of potential surrogate markers of angiogenesisS. Muthuramalingam, Trivadi S. Ganesan, Jeremy Braybrooke et al.|Journal of Clinical Oncology|2004Cited by 2
213 A Phase Ii Study of Etanercept (ENBREL), A Tumour Necrosis Factor-Alpha Inhibitor in Recurrent Ovarian CancerSrinivasan Madhusudan, Trivadi S. Ganesan, S. Muthuramalingam et al.|International Journal of Gynecological Cancer|2004Cited by 1
A randomised trial of carboplatin versus carboplatin and thalidomide in ovarian cancer, with evaluation of potential surrogate markers of angiogenesisS. Muthuramalingam, Trivadi S. Ganesan, Chengcheng Han et al.|Journal of Clinical Oncology|2004Cited by 1